Catriona Yale
2021
In 2021, Catriona Yale earned a total compensation of $1.8M as Chief Development Officer at Akero Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $160,684 |
|---|---|
| Option Awards | $1,190,645 |
| Salary | $401,709 |
| Total | $1,753,038 |
Yale received $1.2M in option awards, accounting for 68% of the total pay in 2021.
Yale also received $160.7K in non-equity incentive plan and $401.7K in salary.
Rankings
In 2021, Catriona Yale's compensation ranked 6,575th out of 12,415 executives tracked by ExecPay. In other words, Yale earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,575 out of 12,415 | 47th |
Division Manufacturing | 2,835 out of 5,508 | 49th |
Major group Chemicals And Allied Products | 1,248 out of 2,378 | 48th |
Industry group Drugs | 1,113 out of 2,099 | 47th |
Industry Pharmaceutical Preparations | 807 out of 1,549 | 48th |
Source: SEC filing on April 28, 2023.
Yale's colleagues
We found four more compensation records of executives who worked with Catriona Yale at Akero Therapeutics in 2021.